Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyveChungen Li, Ke Ding, Caleb Cheng et al.|Journal of Medicinal Chemistry|2023Cited by 18
Abstract 3936: CDK12 tumor suppressor function and therapeutic targeting in newly developed mouse models of serous ovarian cancerJean C. Tien, Arul M. Chinnaiyan, Yali Zhai et al.|Cancer Research|2025Cited by 1
Abstract 2818: Targeting PIKfyve sensitizes gastroenteropancreatic neuroendocrine tumor to mTOR inhibition by disrupting ferritinophagy and lipid homeostasisYizhi Cao, Arul M. Chinnaiyan, Yitong Yin et al.|Cancer Research|2025Cited by 1